Dr. Charles Regis Langelier, MD, PhD

Dr. Langelier practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Langelier's NPI, 1275822793, was assigned on April 5, 2011. Dr. Langelier graduated from Spencer Fox Eccles School of Medicine in 2011. Dr. Langelier holds California license A124890.

Dr. Langelier's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Langelier's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Langelier to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langelier practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Langelier's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Langelier is licensed in California.

CMS data shows 84 Medicare services from Dr. Langelier across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $7,694 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Langelier in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langelier's median patient age at 58, with 46% women.

In 2018, Dr. Langelier wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $235 in total drug cost. In 2017, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Langelier for performance year 2024, reported as part of a group. Dr. Langelier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Langelier as offering telehealth.

Dmand AI links 125 papers to Dr. Langelier, published from 2004 to 2025. 2024 was the busiest year, with 23. The most frequent topics are COVID-19, SARS-CoV-2 and Metagenomics. Dr. Langelier has published most often in medRxiv. Dr. Langelier's most frequent co-authors are Carolyn Suzanne Calfee, MD, Carolyn Marie Hendrickson, MD and Peter Michael Mourani, MD.

CMS Open Payments shows 1 general payment to Dr. Langelier from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Illumina, Inc. paid the most, $241.

Dr. Langelier graduated from Spencer Fox Eccles School of Medicine in 2011.

Dr. Langelier is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.